17-alpha-hydroxyprogesterone has been researched along with beta-Thalassemia in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dahl, KD; Giordano, G; Giusti, M; Guido, R; McGuinness, D; Mori, PG; Valenti, S | 1 |
1 trial(s) available for 17-alpha-hydroxyprogesterone and beta-Thalassemia
Article | Year |
---|---|
Delayed puberty in males with beta-thalassemia major: pulsatile gonadotropin-releasing hormone administration induces changes in gonadotropin isoform profiles and an increase in sex steroids.
Topics: 17-alpha-Hydroxyprogesterone; Adolescent; Adult; Androstenedione; beta-Thalassemia; Dehydroepiandrosterone; Dose-Response Relationship, Drug; Estradiol; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Gonadotropins; Humans; Hydroxyprogesterones; Immunoradiometric Assay; Isomerism; Luteinizing Hormone; Male; Pituitary Gland; Puberty, Delayed; Pulsatile Flow; Radioimmunoassay; Testis; Testosterone | 1995 |